Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,276.00    20.00 (1.59%)
Bid:
1,284.00
Ask:
1,292.00
Spread: 8.00 (0.623%)
Market Cap: £584.74m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Contract Win

13 Aug 2015 07:00

RNS Number : 9010V
Cohort PLC
13 August 2015
Β 

ο»Ώ

13 August 2015

Cohort plc

("Cohort" or "the Group")

Β 

Cohort's MCL subsidiary wins MOD hearing protection contract

Β 

Cohort, the independent technology group, is pleased to announce that its subsidiary Marlborough Communications Ltd. (MCL) has been awarded a contract by the UK Ministry of Defence to provide the armed forces with tactical hearing protection systems for the dismounted close combat userΒ ("THPS DCCU"). The award follows a competitive tender process.

Β 

The initial order value is Β£11.2m. Further orders are expected over the duration of the contract and the delivery schedule and total contract value are still the subject of discussion with the customer. The contract has been awarded for four years, with an option to extend it for a further three years.

Β 

The solution being supplied by MCL was developed in partnership with INVISIO Communications, a leading Danish audio technology company.

Β 

This contract win follows on from MCL's previous UK MOD win earlier in the year, supplying its Tactical In-Ear Protection Plugs as part of the tactical hearing protection system for the basic user soldier.

Β 

Andrew Thomis, Chief Executive of Cohort plc, said:

"We are delighted that MCL has been awarded the THPS DCCU contract. We look forward to working with the UK MOD to deliver this important equipment to soldiers.

"The contract will add significantly to our already strong order book, which substantially underpins our revenues for Cohort's current financial year."

Β 

ENDS

Β 

Β 

For further information please contact:

Cohort plc

Andy Thomis, Chief Executive

Simon Walther, Finance Director

Β 

0118 909 0390

Investec Bank plc

Keith Anderson / Daniel Adams

020 7597 5970

MHP Communications Limited

Reg Hoare / Jamie Ricketts

020 3128 8100

Β 

NOTES TO EDITORS

Β 

Cohort plc (www.cohortplc.com) is the parent company for four innovative, agile and responsive businesses working primarily for defence, wider government and industry clients.

Β 

Β· SCS (www.scs-ltd.co.uk) - a defence consultancy, combining technical expertise with armed forces experience and domain knowledge. Owned by Cohort since flotation in March 2006.

Β· MASS (www.mass.co.uk) - a specialist defence and technology business, focused mainly on electronic warfare, information systems and cyber security. Acquired by Cohort in August 2006.

Β· SEA (www.sea.co.uk) - an advanced electronic systems and software house operating in the defence, transport and offshore energy markets. Acquired by Cohort in October 2007.

Β 

Β· MCL (www.marlboroughcomms.com) - an expert in sourcing, design and integration of communications and surveillance technology, as well as support and training for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014.

Β 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 650 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Devon, Lincolnshire, Somerset, Surrey and Scotland.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
CNTPKBDKABKDQFD
Date   Source Headline
16th Jul 20257:00 amRNSFinal Results
11th Jul 20259:00 amRNS-RInvestor Presentation
11th Jul 20257:00 amRNSNotice of Results
9th Jul 202512:11 pmRNSHolding(s) in Company
1st Jul 202511:00 amRNSTotal Voting Rights
29th May 20257:00 amRNSFull Year Trading Update
12th May 20253:59 pmRNSBlock Listing Application
6th May 20252:00 pmRNS-RContract Win (Replacement)
1st May 20259:00 amRNS-RContract win
1st May 20257:00 amRNSTotal Voting Rights
24th Apr 202512:12 pmRNSDirector/PDMR Shareholding
9th Apr 20253:05 pmRNSDirector/PDMR Shareholding
2nd Apr 202510:41 amRNSBlock Listing Six Monthly Return
1st Apr 20259:58 amRNSTotal Voting Rights
31st Mar 202512:53 pmRNSDirector/PDMR Shareholding
3rd Mar 202512:34 pmRNSTotal Voting Rights
24th Feb 20252:57 pmRNSBlock Listing Six Monthly Return
21st Feb 20252:18 pmRNSDirector/PDMR Shareholding
12th Feb 202511:00 amRNS-RInvestor Presentation via Investor Meet Company
12th Feb 20257:00 amRNSMASS wins extension for JCAST training contract
10th Feb 20257:00 amRNS-RCohort presentation at Shares Spotlight Event
5th Feb 20257:00 amRNS-RInvestor Presentation via Engage Investor
3rd Feb 20255:00 pmRNSTotal Voting Rights
31st Jan 20257:00 amRNSCompletion of EM Solutions Acquisition
24th Jan 20257:00 amRNS-RInvestor Presentation
20th Jan 20257:30 amRNSCompletion date of EM Solutions Acquisition
14th Jan 20257:00 amRNSInterim Report 2024
9th Jan 20257:00 amRNSContract Win
6th Jan 202511:25 amRNSHolding(s) in Company
2nd Jan 20254:44 pmRNSTotal Voting Rights
24th Dec 20248:30 amRNSREVISED COMPLETION OF ACQUISITION
16th Dec 20249:52 amRNSHolding(s) in Company
11th Dec 20242:00 pmRNSHalf Year Results (Replacement)
11th Dec 20247:00 amRNSHalf Year Results
2nd Dec 20242:45 pmRNSTotal Voting Rights
28th Nov 202410:00 amRNSNotice of Half Year Results
21st Nov 202411:26 amRNSResult of the Placing
21st Nov 202411:17 amRNSResult of the Retail Offer
21st Nov 20247:01 amRNSProposed Retail Offer to raise up to £1 million
21st Nov 20247:00 amRNSProposed Placing to raise £40 million
21st Nov 20247:00 amRNSAcquisition of EM Solutions
12th Nov 20249:33 amRNSHolding(s) in Company
4th Nov 20245:42 pmRNSHolding(s) in Company
1st Nov 20245:06 pmRNSTotal Voting Rights
21st Oct 202412:18 pmRNSDirector/PDMR Shareholding
4th Oct 20243:21 pmRNSDirector/PDMR Shareholding
2nd Oct 202411:22 amRNSBlock Listing Six Monthly Return
1st Oct 202411:19 amRNSTotal Voting Rights
24th Sep 20247:00 amRNSAGM Statement
20th Sep 202410:48 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.